Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Higgins Michael J, Chairman & CEO. Insider active across 2 companies, notably Voyager Therapeutics, Inc.. In total, 3 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €93k. History available since 13 January 2022. The latest transaction was filed on 25 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Michael J. Higgins is the Interim President & CEO of Voyager Therapeutics, Inc. In this role, he oversees the company's operations and leads the overall strategy. His experience in the biopharmaceutical sector is valuable in guiding the firm's research and development initiatives.